CXCL10 and infection: Since the current IGRAs are not able to identify those with recently acquired infection who have the highest risk of active tuberculosis, IP-10 response may serve to characterize recently infected cases with the highest risk of progression to active disease, which may receive the greatest benefit from preventive therapy.